These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

61 related articles for article (PubMed ID: 5383463)

  • 1. The effect of L-fucose on rat mammary tumor growth.
    Seltzer MH; Roseman JM; Wolfe DE; Tsou KC; Miller EE; Rosato FE
    Growth; 1969 Dec; 33(4):353-9. PubMed ID: 5383463
    [No Abstract]   [Full Text] [Related]  

  • 2. The effect of L-fucose on rat mammary tumor growth. I. In vivo studies.
    Wolfe D; Roseman JM; Miller E; Seltzer MH; Rosato FE
    J Surg Oncol; 1971; 3(1):73-7. PubMed ID: 5093805
    [No Abstract]   [Full Text] [Related]  

  • 3. Further observations of L-fucose as a specific inhibitor of rat mammary carcinoma in tissue culture.
    Wolfe DE; Roseman JM; Seltzer MH; Miller EE; Rosato FE
    Growth; 1970 Dec; 34(4):379-84. PubMed ID: 5504505
    [No Abstract]   [Full Text] [Related]  

  • 4. Effect of hydroxyurea and related compounds on HMC mammary tumor growth and nucleic acids in Fischer rats.
    Hilf R; Bell C; Michel I; Freeman JJ; Borman A
    Cancer Res; 1966 Nov; 26(11):2286-91. PubMed ID: 5956631
    [No Abstract]   [Full Text] [Related]  

  • 5. Chemically induced autochthonous tumor models in experimental chemotherapy.
    Zeller WJ; Berger MR
    Behring Inst Mitt; 1984 May; (74):201-8. PubMed ID: 6477353
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The effect of L-fucose on rat mammary tumor growth. II. In vitro studies.
    Roseman JM; Miller E; Seltzer MH; Wolfe D; Rosato FE
    J Surg Oncol; 1971; 3(1):79-88. PubMed ID: 5093806
    [No Abstract]   [Full Text] [Related]  

  • 7. Effect of hydroxyurea on growth of a transplantable mouse mammary adenocarcinoma.
    Lerner LJ; Bianchi A; Dzelzkalns M
    Cancer Res; 1966 Nov; 26(11):2297-300. PubMed ID: 5956633
    [No Abstract]   [Full Text] [Related]  

  • 8. Increased mannose 6-phosphate/insulin-like growth factor II receptor and transforming growth factor beta 1 levels during monoterpene-induced regression of mammary tumors.
    Jirtle RL; Haag JD; Ariazi EA; Gould MN
    Cancer Res; 1993 Sep; 53(17):3849-52. PubMed ID: 8358708
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Induced mammary carcinoma in the female rat as a drug evaluation system.
    Griswold DP; Skipper HE; Laster WR; Wilcox WS; Schabel FM
    Cancer Res; 1966 Oct; 26(10):2169-80. PubMed ID: 5921488
    [No Abstract]   [Full Text] [Related]  

  • 10. Continuous intravenous fucose therapy in rat mammary cancer. II.
    Mullen JL; Rosato FE; Allen TR; Miller EE; Roseman J; Rosato EF
    J Surg Oncol; 1973; 5(1):61-9. PubMed ID: 4709287
    [No Abstract]   [Full Text] [Related]  

  • 11. Suberoylanilide hydroxamic acid (SAHA), a histone deacetylase inhibitor, suppresses the growth of carcinogen-induced mammary tumors.
    Cohen LA; Marks PA; Rifkind RA; Amin S; Desai D; Pittman B; Richon VM
    Anticancer Res; 2002; 22(3):1497-504. PubMed ID: 12168829
    [TBL] [Abstract][Full Text] [Related]  

  • 12. LAS, a novel selective estrogen receptor modulator with chemopreventive and therapeutic activity in the N-nitroso-N-methylurea-induced rat mammary tumor model.
    Cohen LA; Pittman B; Wang CX; Aliaga C; Yu L; Moyer JD
    Cancer Res; 2001 Dec; 61(24):8683-8. PubMed ID: 11751385
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effects of 17-alpha-thioestradiol, 2 estradiol analogs, and 2 androgens on 7,12-dimethylbenz[a]anthracene-induced rat mammary tumors.
    Teller MN; Stock CC; Bowie M
    Cancer Res; 1966 Nov; 26(11):2329-33. PubMed ID: 5956637
    [No Abstract]   [Full Text] [Related]  

  • 14. Growth inhibition of estrogen-sensitive rat mammary tumors. Effect of an alpha-fetoprotein-secreting hepatoma.
    Sonnenschein C; Ucci AA; Soto AM
    J Natl Cancer Inst; 1980 May; 64(5):1147-52. PubMed ID: 6154169
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A novel aromatase inhibitor, vorozole, shows antitumor activity and a decrease of tissue insulin-like growth factor-I level in 7, 12-dimethylbenz[a]anthracene-induced rat mammary tumors.
    Sugamata N; Koibuchi Y; Iino Y; Morishita Y
    Int J Oncol; 1999 Feb; 14(2):259-63. PubMed ID: 9917500
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Inhibition of metastasis by cicaprost in rats with established SMT2A mammary carcinoma growth.
    Schirner M; Schneider MR
    Cancer Detect Prev; 1997; 21(1):44-50. PubMed ID: 9043762
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Suppressive effect of iodine on DMBA-induced breast tumor growth in the rat.
    Funahashi H; Imai T; Tanaka Y; Tobinaga J; Wada M; Morita T; Yamada F; Tsukamura K; Oiwa M; Kikumori T; Narita T; Takagi H
    J Surg Oncol; 1996 Mar; 61(3):209-13. PubMed ID: 8637209
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Sonodynamic therapy on chemically induced mammary tumor: pharmacokinetics, tissue distribution and sonodynamically induced antitumor effect of gallium-porphyrin complex ATX-70.
    Yumita N; Okuyama N; Sasaki K; Umemura S
    Cancer Chemother Pharmacol; 2007 Nov; 60(6):891-7. PubMed ID: 17426974
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Levels of cyclic nucleotides in autotransplanted 7, 12-dimethylbenz[a]anthracene-induced rat mammary tumors during their growth and regression.
    Lee C
    J Natl Cancer Inst; 1980 Nov; 65(5):1029-32. PubMed ID: 6253705
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Chronotherapy of breast cancer induced by N-nitrosomethylurea in the rat. I. Effect of a high dose of cyclophosphamide administered at 8:00 and 14:00 hours].
    Pérez-López FR; Urcia M; Torralba R; Lafarga L; Leal MC; Guillén V; Hergueta J
    Rev Esp Oncol; 1984; 31(3):401-7. PubMed ID: 6546168
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.